Investieren Sie in Sachwerte! 130.000 Anleger sind schon auf BERGFÜRST dabei. ✓ 7,5 % bis 10 % Zinsen p.a. ✓ Kurze Laufzeiten ✓ Kein Mindestanlagebetrag
What is De's Revenue?
De's estimated revenue is $2M.
What does De do?
Investieren Sie in Sachwerte! 130.000 Anleger sind schon auf BERGFÜRST dabei. ✓ 7,5 % bis 10 % Zinsen p.a. ✓ Kurze Laufzeiten ✓ Kein Mindestanlagebetrag
BERGFÜRST awful investments
I made 5 investments with Bergfuerst, no one is going well. Just as an example: I provided money more than 4 years ago, there are no information for the last 9 months, it is written that the investment has to be closed within March 2025 on their platform. Reply from Bergfuerst: you will always receive the latest information in your digital mailbox in your BERGFÜRST account. The BERGFÜRST support cannot send you any other news. Only the issuer itself or the security trustee can do this - and they only ever communicate via your digital mailbox. In this respect, I must ask for your patience or refer you to your mailbox. The information provided there will always reflect the current status I leave the judgement to readers Reading your answer you did not catch the issue. You do not care of your investors. I showed a case where there is no inputs for many months, already reviewed commitments are past due and you say I cannot do anything. It's a shame.
No updates, just blind driving
I invested in a project and waited for more than two years. No updates, no news, nothing. And just 1 month before the end date, I received an information that the project can not deliver the promises and asking for an extension. I am aware of the investment risk here, but getting no updates is another issue and I expect that from Bergfürst
Technology detection powered by advanced web analysis
Powered byTechlist.aiStaydomio
Immunomedics
Vettery
Learn about LHH, with our global network of colleagues who bring local knowledge and experience to support millions of people across the full talent lifecycle.More
Livetiles
Sema4
The #1 genomic test, preferred by more than 80% of genetic and pediatric providers1. Delivering precise, fast, and actionable diagnoses.More